Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Veracyte Inc (VCYT)

Veracyte Inc (VCYT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Veracyte Inc 6000 SHORELINE COURT SUITE 300 SOUTH SAN FRANCISCO CA 94080 USA

www.veracyte.com Employees: 755 P: 650-243-6300 F: 650-243-6388

Sector:

Medical

Description:

Veracyte, Inc. is a diagnostics company. It is focused on discovering, developing and commercializing molecular cytology solutions. The Company provides Afirma Thyroid FNA Analysis, which helps physicians in reducing unnecessary diagnostic surgeries for patients with thyroid nodules. Veracyte is also developing Afirma Malignant GEC test. It serves endocrinologists, radiologists, and head and neck specialists. Veracyte, Inc. is headquartered in South San Francisco, California.

Key Statistics

Overview:

Market Capitalization, $K 2,689,653
Enterprise Value, $K 2,327,073
Shares Outstanding, K 79,458
Float, K 78,346
% Float 98.60%
Short Interest, K 6,052
Short Float 7.62%
Days to Cover 6.53
Short Volume Ratio 0.49
% of Insider Shareholders 1.40%

Financials:

Annual Sales, $ 517,150 K
Annual Net Income, $ 66,350 K
Last Quarter Sales, $ 140,640 K
Last Quarter Net Income, $ 41,150 K
EBIT, $ 60,270 K
EBITDA, $ 78,420 K

Growth:

1-Year Return 4.22%
3-Year Return 48.77%
5-Year Return -35.81%
5-Year Revenue Growth 340.20%
5-Year Earnings Growth 287.88%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.53 on 02/25/26
Next Earnings Date 05/06/26
Earnings Per Share ttm 1.27
EPS Growth vs. Prev Qtr 5.26%
EPS Growth vs. Prev Year 66.67%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

VCYT Ratios

Ratio
Price/Earnings ttm 27.31
Price/Earnings forward 28.96
Price/Earnings to Growth N/A
Return-on-Equity % 8.05%
Return-on-Assets % 7.38%
Profit Margin % 12.83%
Debt/Equity 0.00
Price/Sales 5.33
Price/Cash Flow 23.28
Price/Book 2.09
Book Value/Share 16.57
Interest Coverage -1.29
60-Month Beta 1.91
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar